GEN | News Highlights: Novartis’ Onbrez Breezhaler Trumps Salmeterol in Phase III COPD Trial

Links shared publicly online about this topic.

  • 867
    total visits

GEN | News Highlights: Novartis’ Onbrez Breezhaler Trumps Salmeterol in Phase III COPD Trial

genengnews.com —

Once-daily treatment provided better 24-hour bronchodilation than twice-daily salmeterol.

View full resource at genengnews.com

Tags:

  • Share

Most Recently Shared on September 20, 2010 at 4:17 pm By:

SPulim Sandeep Pulim

RT @GENbio: Novartis’ Onbrez Breezhaler Trumps Salmeterol in Phase III COPD Trial http://bit.ly/c6PhY1

2 years ago...

Reply

Retweet

Favorite

Advertisement